











Exocrine pancreatic secretion is largely controlled by the
autonomic nervous system. We and other investigators
have clearly demonstrated that the vago-vagal reflex plays
a crucial role in the mediation of postprandial pancreatic
enzyme secretion. Previous studies in the rat showed that
cholecystokinin (CCK) (Li & Owyang, 1993b, 1994; Li et
al. 1997) and luminal non-CCK-dependent factors (Li &
Owyang, 1996b) such as osmolality, disaccharides, and
mechanical stimulation evoke pancreatic secretion via
intestinal vagal mucosal afferent fibres. We recently
demonstrated that 5-HT released from intestinal
enterochromaffin cells acts as a paracrine substance to
mediate luminal non-CCK-stimulated pancreatic secretion
(Li et al. 2000). Although pancreatic secretion can be
mediated by vago-vagal reflexes located within the
brainstem, these reflexes may be modulated by input from
higher centres (Rogers et al. 1996).
It has been recognized since Pavlov’s time (Pavlov, 1910)
that the CNS exerts considerable control over the cephalic
phase of pancreatic secretion (Sarles et al. 1968). The
hypothalamus receives a wide variety of convergent afferent
inputs from the viscera and regulates autonomic activities
by modulating neuronal input to autonomic preganglionic
neurons. With the exception of the pioneering work of
Gilsdorf et al. (1966), which suggested the involvement of
the hypothalamus in regulating pancreatic secretion,
the physiological significance of forebrain input in the
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mediation of postprandial pancreatic secretion has
remained largely unexplored.
Muscarinic receptors are widely distributed in the brain,
including the hypothalamus and the vagal nucleus, and
central muscarinic actions are potentially widespread
(Whittaker, 1988). Previous studies have shown that the
central cholinergic pathway contributes significantly to
the regulation of digestive functions, including salivation
(Tomic-Beleslin & Beleslin, 1986), gastric secretion (Grill
& Norgren, 1978), gastric dysrhythmias (Hasler et al.
1995), emesis (Pedigo & Brizzee, 1985), and the
oesophagomotor response (Lu & Bieger, 1998). Endocrine
pancreatic polypeptide (PP) cells within the pancreatic
islets and scattered throughout the exocrine tissue
synthesize and release PP (Taylor, 1989). The plasma PP
response is a reliable index of vagal cholinergic input to the
pancreas. Infusion of atropine into the lateral cerebral
ventricle is known to abolish fluctuations of basal PP levels
and also PP secretion stimulated by hypoglycaemia or food
intake (Okita et al. 1997), which suggests involvement of
the central muscarinic cholinergic system in the regulation
of vagal efferent input to the pancreas.
We have shown that peripheral cholinergic blockade
completely abolishes pancreatic secretion (Li & Owyang,
1993b, 1994). The role of central cholinergic neurons in
the regulation of pancreatic secretion, however, is unknown.
Choline acetyltransferase immunoreactivity is abundant
in the CNS, including the septal nuclei, parabrachial
nucleus (PBN), bed nucleus, amygdala, and hypothalamus
(Ruggiero et al. 1990). We hypothesize that involvement of
the vago-vagal reflex in mediating pancreatic secretion is
under central control and regulated by cholinergic pathways
in the hypothalamus. In this study, we performed in vivo
pancreatic secretion studies in the conscious rat and
investigated the effects of chronic decerebration on basal
and stimulated pancreatic enzyme secretion. To localize
the sites of action, we examined the effects of micro-
injection of methscopolamine (MSCP) into the dorsal
motor nucleus of the vagus (DMV), the lateral hypothalamic
nucleus (LH) and the paraventricular nucleus (PVN) on
pancreatic secretion evoked by luminal stimuli. In addition,
we investigated the role of endogenous ACh on basal and
stimulated pancreatic secretion by administration of intra-
cerebroventricular (I.C.V.) injections of hemicholinium-3 at
doses known to deplete the endogenous ACh store. To
identify the sites of cholinergic neurons responsible for
modulating pancreatic secretion, we examined the effects
of selective destruction of cholinerginc neurons on
pancreatic secretion: immunotoxin 192 IgG-saporin-
induced lesion of the cholinergic basal forebrain neurons
and ibotenic acid-induced lesion of the PBN. To determine if
lateral septal or lateral PBN (LPBN) stimulation activates
the vagal pancreatic efferent nerve, electrophysiological
activity of the vagal pancreatic nerve was recorded.
METHODS 
Materials
Peptone, (_)scopolamine methyl nitrate (MSCP), hemicholinium-
3, and McN-A-343 were purchased from Sigma-Aldrich (St Louis,
MO, USA). Ibotenic acid was obtained from Research Biochemicals
International (Natick, MA, USA). 192 IgG-saporin was purchased
from CHEMICON International, (Temecula, CA, USA).
Animal preparation
All protocols used in this study were approved by the University
Committee on Use and Care of Animals at the University of
Michigan. After an overnight fast, male Sprague-Dawley rats
weighing 250–300 g were anaesthetized with a mixture of xylazine
and ketamine (13 and 87 mg (kg body weight)_1, respectively,
I.M.). One-third of the initial anaesthetic dose was given every
90 min thereafter to maintain surgical anaesthesia. This
anaesthetic procedure was used to prepare rats for all studies
described, including chronic decerebration, brain cannulation,
brain nuclei lesion, and re-anaesthetization of the rats for
pancreatic efferent nerve recording. At the end of each
experiment, the rats were killed with a barbiturate overdose
(70 mg kg_1, I.V.).
Chronic decerebration. To quantify pancreatic secretion
contributed by the rat forebrain, we performed chronic
decerebration, a classical method designed to remove the
influence of the forebrain. The procedure involves placing the rat
in a stereotaxic frame, removing the dura, and then transecting the
brain at the supracollicular level in a two-stage procedure using a
handheld spatula (Grill & Norgren, 1978; DiRocco & Grill, 1979).
Chloramphenicol (1 % solution) was applied to the exposed scalp
prior to closure to limit local infection. Completeness of the
transection was verified histologically in all cases.
Nursing care. The decerebrate rats were incapable of effective
thermoregulation or spontaneous feeding or drinking, but they
were capable of consuming orally administered fluids (Steiner,
1973). Body temperature was maintained between 34 °C and
37.5 °C by warming or evaporative cooling. Rectal temperature
was recorded 3 times daily. The decerebrate rats and the controls
were tube fed three 12-ml meals daily consisting of equal parts
sweetened condensed milk and water (with a multiple vitamin
supplement). The animals were housed individually and
subjected to a 12-h day : 12-h night cycle. Pancreatic secretion
studies were performed 7–10 days after decerebration.
Intracerebroventricular cannulation. The animal was placed in a
stereotaxic unit with the upper incisor bar placed 3 mm above the
interaural line. A small hole was drilled into the skull, through
which a 15-mm-long stainless steel cannula (24 gauge) was
introduced perpendicularly into the middle of the left cerebral
ventricle. The cannula was secured with two screws inserted into
the surface of the parietal bone and fixed with cranioplastic
powder (Plastics One). Coordinates from the bregma were as
follows: anteroposterior, 0.6 mm; lateral, 2 mm; and ventral,
4 mm.
DMV cannulation. Brain nuclei microinjection in conscious rats
was accomplished by implanting a unilateral guide cannula into
the DMV using an adaptation of a technique described by
Michelini & Bonagamba (1988) and Callera et al. (1997). A small
window was opened caudal to the lambda, through which a 15-
mm-long stainless steel cannula (24 gauge) was introduced
perpendicularly, 14 mm caudal to the bregma, 0.5 mm lateral to












the midline, 8.3 mm below the skull surface. The guide cannula
was fixed to the skull with methacrylate and watch screws and
closed with an occluder until the time of experimentation. The
33-gauge needle used to administer microinjections into the
DMV measured 1.5 mm longer than the guide cannula and was
connected by polyethylene tubing to a microinfusion pump for
intracranial drug delivery.
Hypothalamic nuclei cannulation. The guide cannula was
introduced into the hypothalamic region at the following
coordinates: LH: 2.2–2.8 mm posterior, 1.6–1.9 mm lateral,
7.2–7.8 mm below the skull surface; PVN: 1.8 mm posterior to the
bregma, 0.8 mm lateral to the midline, and 8.0 mm below the
skull surface. For the control treatment, the cannula was inserted
in the vicinity of the PVN and LH but outside their borders.
After 3–4 days, pancreatic enzyme secretion studies were
performed in conscious rats. We observed that brain nucleus
cannulation did not alter feeding and drinking behaviour and the
rats gained an average of 6.1 g in 7 days.
Septal nuclei and LPBN cannulation. To perform septal nuclei
and LPBN microinjection during electrophysiological recording
of vagal pancreatic efferent nerve, unilateral guide cannulas were
inserted at the following coordinates: lateral septal nucleus (LS):
1.0 mm rostral to the bregma, 0.8 mm lateral to the midline, and
5.7 mm below the skull surface; the lateral PBN: 9.4 mm caudal to
the bregma, 2.2 mm lateral to the midline and 4.1 mm below the
skull surface. On completion of each experiment the rats were
killed with a barbiturate overdose (70 mg kg_1, I.V.). The brain was
removed and fixed in a formalin–20 % sucrose solution for 2 days.
Serial coronal sections (30 mm) were cut, stained by the Nissl
method, and examined microscopically. The location of the
microinjection was determined to be the point of termination of
the cannula track and marked on the plates reproduced from the
atlas of the rat brain by Paxinos & Watson (1998).
Immunotoxic lesions of cholinergic neurons by 192 IgG-
saporin. Wiley et al. (1992) developed an excellent tool for
selectively lesioning cholinergic basal forebrain neurons. Previous
studies have shown that injection of 192 IgG-saporin (10 ng) into
the nucleus basalis magnocellularis (NBM) provided the greatest
loss of cholinergic cells that project to the cortex, without loss of
hippocampal afferents and with limited loss of striatal cholinergic
cells (Wenk et al. 1994). Injection of 192 IgG-saporin at a dose of
0.22 mg into the medial septum (MS) resulted in no apparent loss
of parvalbumin, a calcium-binding protein that serves as a marker
for GABAergic projection neurons in the MS (Johnson et al.
2002), which suggests the selective destruction of cholinergic
neurons. In the current study, we used 192 IgG-saporin (10 ng in
0.03 ml) in sterile PBS, a concentration known to induce the
greatest loss of cholinergic cells (Wenk et al. 1994). A micropipette
tip (outside diameter 40–60 mm) was placed in the MS
(coordinates: 0.45 mm anterior and 0.2 mm lateral to the bregma,
and 5.7 mm below the skull surface), the lateral septum (LS)
(1.0 mm anterior and 0.8 mm lateral to the bregma, and 5.7 mm
below the skull surface), and the NBM (0.9 mm posterior to the
bregma, 2.8 mm lateral to the midline, and 7 mm below the skull
surface). A 0.03 ml solution was delivered for 2 min at each site.
The lesioned animals generally took longer to recover from the
effects of the anaesthetic than the sham-lesioned controls. They
appeared more lethargic and were less inclined to eat or drink after
surgery. Postoperative weight loss was universal, but 3 days after
surgery, sham- and MS-, LS-, NBM-cholinergic ablated animals
showed a daily weight gain. Experimentation began on the 10th
postoperative day.
Immunohistochemistry. After pancreatic secretion studies, at
least two rats from each group were used for histological studies.
The rats were deeply anaesthetized with sodium pentobarbital
(100 mg kg_1) and perfused transcardially with saline followed by
10 % formalin. The brain was quickly removed. Serial coronal
sections (40 mm) were cut through the basal forebrain. The
sections were incubated in polyclonal mouse anti-choline
acetyltransferase (MAB 305, 1:600, CHEMICON International,
Temecula, CA, USA) in PBS-TX containing 0.1 % BSA (PBS-
TX–BSA) for 12 h at 4 °C. The specimens were rinsed three times
with PBS-TX–BSA, then incubated for 60 min at 35 °C with a
secondary antibody (donkey-mouse Cy3) (1:200) in PBS-
TX–BSA. The specimens were examined with a fluorescence
microscope (Nikon Optiphot-2) using appropriate excitation
wavelengths (550–570 nm). One set from each of the brains was
counterstained with neutral red to facilitate identification of the
neurons. Brain tissue from unoperated rats was processed in
parallel as a positive control.
Ibotenic acid lesions of the PBN. Cholinergic neurons in the
parabrachial nucleus send direct input to the hypothalamic
nuclei, including the LH and PVN (Saper & Loewy, 1980). PBN
cholinergic neurons do not display nerve growth factor receptor
(NGFr) staining and are unaffected by 192 IgG-saporin injections
(Heckers et al. 1994). In this study, we used the neurotoxin
ibotenic acid to lesion the PBN. It has been shown in rodents that
viscerosensory neurons are located in the LPBN (Fulwiler &
Saper, 1984; Herbert et al. 1990), and the gustatory responsive
neurons are found in the medial subdivisions of the PBN (MPBN)
(Halsell & Frank, 1991). After a scalp incision, two holes were
drilled into the skull to provide access to the bilateral LPBN at the
following coordinates: 9.4 mm caudal to the bregma, 2.2 mm
lateral to the midline, and 6 mm below the surface of the skull.
Access to the MPBN was achieved at the following coordinates:
11.5 mm posterior to the bregma and 1.0–1.5 mm lateral to the
midline. A micropipette was back-filled with ibotenic acid
immediately prior to injection; a 0.15-ml dose (20 mg ml_1) was
infused over 10 min. To minimize spread of the neurotoxin along
the track, the micropipette remained in situ for an additional
10 min before the procedure was repeated on the contralateral
site. At the completion of the surgical procedure, the scalp incision
was closed with wound clips. The experiment was started after
3 weeks’ postoperative recovery.
Histology. Serial coronal sections (50 mm) were cut at on a
cryostat, mounted on gelatin-coated slides, and stained with cresyl
violet. The extent of the lesions was determined by examining the
sections under a light microscope, and reconstructions were made
on charts derived from the atlas of Paxinos & Watson (1998).
Postoperative care
Sterile isotonic saline (10 ml, subcutaneous) was administered to
prevent dehydration during recovery, and bicillin (0.5 ml,
300 000 U ml_1, intramuscular) to prevent infection. On
completion of surgery, rats were placed on a warm recovery pad
and their general condition was monitored. After recovery from
the anaesthesia, the rats were returned to the animal quarters and
their body weight and general behaviour were monitored daily.
Lidocaine (lignocaine) was applied locally to the scalp to reduce
discomfort. Diluted Tylenol (50 mg kg_1, cherry flavoured) was
available for 24 h after surgery.












Pancreatic secretion studies in conscious rats. For the
physiological studies, we used a conscious rat model in which a
chronic pancreatic and duodenal catheter was passed through a
modified plastic housing (Li et al. 1997) sutured to the abdominal
ventral wall. One end of the tubing (PE-10 or PE-50, Clay-Adams,
Becton, Dickinson and Company, Sparks, MD, USA) was inserted
into the common bile-pancreatic duct, and the other end was
placed in the duodenum through a cannula (PE 60 or PE 190)
fixed in the housing. After surgery, the animals were returned to a
regular cage for 4 days to recover until the experiments were
performed. During the experiment, the pancreatic catheter was
gently disconnected from the duodenal cannula for the collection
of bile–pancreatic juice.
After a 30-min stabilization period, combined biliary–pancreatic
secretions were collected every 15 min. The volume was measured
and an aliquot was taken and diluted with distilled water for
protein determination. The remaining undiluted bile–pancreatic
juice was pumped back into the rat through the duodenal cannula
during the next collection period at the secretion rate of the
preceding collection period. Protein in the bile–pancreatic juice
was measured spectrophotometrically using the assay method of
Bradford (Li et al. 2000). In a previous study, we confirmed that
the increase in protein output in the bile–pancreatic juice after
CCK-8 and non-CCK luminal stimulation (authors’ unpublished
observations) reflected protein from the pancreatic source. Biliary
juice protein did not increase in response to CCK stimulation.
Duodenal perfusion studies. Previous research (Li et al. 1996b)
showed that pancreatic secretion in response to intraduodenal
perfusion of peptone is mediated by endogenously released CCK.
We have also shown that intestinal 5-HT released from
enterochromaffin cells mediates pancreatic secretion stimulated
by luminal hypertonic NaCl solution (Li et al. 2000). Both CCK
and 5-HT act via stimulation of vagal afferent pathways to evoke
pancreatic secretion. In the present study these methods were
used to examine the role of the CNS in mediating pancreatic
secretion evoked by the vago-vagal reflex. After a 45-min basal
period, 5 % peptone or hypertonic NaCl (600 mosmol l_1) was
perfused into the duodenum at a constant rate of 3 ml h_1 by a
peristaltic pump. The vehicle and two test solutions were
administrated separately in random order, each for 75 min, with a
45-min resting period between each test to allow pancreatic
secretion to return to basal level. In the first group of rats prepared
with I.C.V. cannulas, after a 30-min basal collection of
bile–pancreatic juice, I.C.V. infusion of vehicle solution (6 ml) was
followed by intraduodenal infusion of peptone and hypertonic
NaCl. The next day, the same rats received an I.C.V. infusion of the
blood–brain barrier-impermeant cholinergic muscarinic receptor
antagonist MSCP (5 or 50 nmol (6 ml)_1). To determine if
endogenous acetylcholine plays a physiological role in the
mediation of pancreatic secretion, we examined the effects of I.C.V.
infusion of hemicholinium-3 (20 mg in 6–8 ml, dissolved in saline,
delivered over 1 min) in a separate group of rats, The internal
cannula was kept in position for 45 s before being retracted.
Pancreatic secretion studies were performed. Immediately before
killing the rats, 2 ml of methylene blue was administered by I.C.V.
injection to verify the injection site. Data from animals that did
not display the dye throughout the ventricular system were
excluded from analysis. To localize the sites of action of MSCP, we
performed brain nucleus microinjection studies. In separate
groups of rats prepared with DMV, LH, or PVN cannulas,
vehicle or MSCP (40 nl (15 s)_1) was delivered by a
microinjector (David Kopf Instruments, Tujunga, CA, USA).
Intraduodenal perfusion studies were performed after the
injection.
Pancreatic secretion studies were also conducted in rats 10 days
after septal nuclei and NBM cholinergic lesion by 192 IgG-
saporin, and in rats 3 weeks after PBN lesion by ibotenic acid. In
the another series of experiments, after a 30-min basal collection,
vehicle or ACh (5 pmol) or the muscarinic M1 receptor agonist
McN-A-343 (20 pmol) was microinjected into the DMV, LH, and
PVN, and pancreatic secretion studies were performed.
On completion of each experiment, minimal changes were
observed in the animals’ general behaviour, such as locomotor
activity, grooming, and rearing to the side or in the centre of the
cage, suggesting that microinjection of various agents did not
cause distress.
Electrophysiological recording of vagal pancreatic efferent
nerve
After 5 days of recovery, the rats prepared with LPBN or LS
cannulas were re-anaesthetized, and prepared with a tracheal tube
that permitted artificial ventilation with room air. Body
temperature was maintained with a special heating pad. The
pancreatic nerve of the vagus running along the side of the splenic
artery was isolated from the central cut end, and efferent nerve
activity was recorded using bipolar platinum electrodes. A strip of
connective tissue was wrapped around the second indifferent
electrode. Multi-unit efferent recordings were thus obtained from
the vagal pancreatic nerve. The electrophysiological signal was
amplified by an A-M system, high-input impedance that was
preamplified and monitored with an oscilloscope and audio
monitor. The discharges were displayed and stored electronically
using Axon tape software (Axon Instruments) and a 166-MHz
Pentium processor for off-line computer analysis. After 5 min of
recording the vagal pancreatic nerve firings to confirm the
stability of the firing frequency, basal discharge was monitored for
5 min. Discharge frequency after microinjection of glutamate
(30 nmol (50 nl)_1) into the LPBN was measured over 20 min. At
the completion of the electrophysiological study, the same rats
were subjected to the pancreatic secretion study in response to
glutamate injection into the LPBN.
At the end of each experiment, the rats were killed with a
barbiturate overdose (70 mg kg_1, I.V.). The brain was removed,
and stored in formalin–20 % sucrose solution for 2 days, and serial
coronal sections (20 mm) were cut and stained by the Nissl
method. Histological sections were examined microscopically.
The location of the microinjection site was determined to be the
point of termination of the cannula track and was marked on the
plates reproduced from the rat brain atlas of Paxinos & Watson
(1998).
Data analysis. Off-line single-unit analyses were performed using
the Datapac software system 2000 (Run Technologies, Laguna
Hills, CA, USA), and the spike sorting module software (Li et al.
1999). Time histograms were constructed for all final 30 s
recordings. The basal discharge frequency and the stimulus-
induced discharge frequency were determined by calculating the
average volume of all 30 s periods in 3 min. The results were
compared with those obtained after I.C.V. injection of MCSP.
Statistical analysis
Results were expressed as means ± S.E.M. Multivariate ANOVA
was used to evaluate the effects of repeated measurements over
time, the effects of treatment, and the interaction between these
two variables. Basal output was determined to be the average of












two 15-min periods. The cumulative net increase in protein
output was calculated as the sum of protein output during the
final 30 min of intestinal infusion of peptone or hypertonic NaCl
minus the basal output. Zero cumulative output was considered
to reflect 100 % inhibition. Subsequent comparisons were made
with the Newman-Keuls test (InStat Biostatistics 2.01. Graphpad
Software, Inc.).
RESULTS
Effects of chronic decerebration on pancreatic
secretion in conscious rats
The chronically decerebrate rats were sufficiently
coordinated to groom their fur. Although they exhibited
relative immobility, they often overreacted with well-
coordinated movements such as running and jumping
(Tang, 1955). Previous studies have shown that chronically
decerebrate rats retain the capacity to increase plasma
glucose concentration in response to 2-deoxyglucose
(DiRocco & Grill, 1979). In this study, both sham-
operated (n = 4) and decerebrate rats (n = 6) showed a
weight gain: 245 ± 6 g (sham-operated) and 248 ± 8 g
(decerebrate) before surgery to 262 ± 6 and 260 ± 10 g on
the 10th day after surgery. Basal pancreatic secretion rates
averaged 318 ± 12 mg h_1 in conscious rats. Duodenal
infusion of 5 % peptone or hypertonic NaCl at 3 ml h_1
increased protein secretion in sham-operated rats to
588 ± 9 and 569 ± 13 ml h_1, respectively, an 85 % and
79 % increase in protein output over basal (Fig. 1A and B).
The cumulative net increases in protein output were
130 ± 15 and 122 ± 12 mg (30 min)_1, respectively. Chronic
decerebration caused a reduction in basal pancreatic
protein output to 233 ± 9 mg h_1. In response to duodenal
infusion of 5 % peptone or hypertonic NaCl, the
pancreatic protein output in decerebrate rats increased to
354 ± 11 and 301 ± 14 mg h_1, respectively, representing
50 % and  36 % increases over basal (Fig. 1A and B). The
cumulative net increases in protein output were 60 ± 7
and 50 ± 9 mg (30 min)_1, respectively (Fig. 1C). Thus,
compared to controls, chronic decerebration resulted in
46 % and 40 % less pancreatic protein secretion in
response to luminal perfusion of, respectively, peptone
and hypertonic NaCl.
Effects of I.C.V. administration of MSCP on
pancreatic secretion stimulated by peptone and
hypertonic NaCl
An I.C.V. injection of 5 nmol MSCP had no effect on basal
pancreatic protein output, whereas a dose of 50 nmol
decreased basal pancreatic protein output from 320 to
210 mg h_1 (Fig. 2A). I.C.V. infusion of MSCP produced a
partial inhibition of pancreatic secretion stimulated by
luminal peptone and hypertonic NaCl (Fig. 2B). The
cumulative net increases in protein output were
70 ± 6 mg (30 min)_1 after infusion of peptone, and
57 ± 4 mg (30 min)_1 after infusion of hypertonic NaCl
(Fig. 2B and C). Compared to controls, these results
represent a 47 % and 56 % reduction in response to,
respectively, intestinal peptone and hypertonic NaCl
stimulation.
Effects of microinjection of MSCP into the LH on
basal and pancreatic secretion in response to
luminal stimulation in conscious rats
Bilateral LH injection of MSCP at a dose of 5 nmol resulted
in a significant decrease of basal pancreatic secretion from
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Figure 1. Effects of chronic decerebration on pancreatic secretion in conscious rats
Chronic decerebration induced a decrease in basal pancreatic enzyme secretion from 318 ± 12 to
233 ± 9 mg h_1 and a reduction in pancreatic secretion stimulated by intraduodenal infusion of 5 % peptone
(A) and hypertonic NaCl (B) by 54 % and 45 %, respectively. C, cumulative net increase in pancreatic protein
output (i.e. the sum of protein output during the final 30 min of intestinal infusion of peptone or hypertonic
NaCl minus basal output in sham-operated and decerebrate rats). These observations indicate that the
forebrain plays an important role in maintaining basal pancreatic secretion and in modulating vagal afferent-
stimulated pancreatic secretion. Values are means ± S.E.M. for 4 sham-operated and 6 decerebrate rats.












320 ± 11 to 219 ± 17 mg h_1 (n = 4) (Fig. 3A). The
inhibitory effect lasted 60 min. This observation indicates
that cholinergic tone in the hypothalamus regulates basal
pancreatic secretion. Bilateral microinjection of MSCP into
the LH reduced the cumulative net increase in protein
output in response to duodenal perfusion of peptone from
120 ± 6 to 71 ± 8 mg (30 min)_1 (Fig. 3B and C). Injection of
MSCP near but outside the LH, specifically into the magno-
cellular preoptic nuclei (n = 1) and the anterior hypo-
thalamic area (n = 1) did not affect the pancreatic protein
secretion. These rats were excluded from the statistical
analyses. These observations suggest that muscarinic
cholinergic receptors in the LH are involved in regulating
pancreatic secretion evoked by the vago-vagal reflex.
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Figure 2. Effects of intracerebroventricular administration of the cholinergic antagonist
methscopolamine on pancreatic secretion in conscious rats
A, intracerebroventricular (I.C.V.) administration of methscopolamine (MSCP) at a dose of 5 nmol had no
effect on basal pancreatic protein output, whereas a 50-nmol dose induced a decrease in basal pancreatic
protein output from 320to 210 mg h_1. B, intraduodenal infusion of peptone and hypertonic NaCl increased
protein secretion by 100 % and 70 %, respectively. We have previously shown that these responses are
mediated by a vagal mucosal afferent pathway. I.C.V. MSCP administration partially inhibited pancreatic
protein output stimulated by peptone or hypertonic NaCl. C, cumulative net increase in pancreatic protein
output in response to intraluminal peptone or hypertonic NaCl was significantly reduced in decerebrate rats
compared to controls. Values are means ± S.E.M. for 4 rats in each group. * P < 0.05 compared with sham
operation.
Figure 3. Effects of bilateral microinjection of methscopolamine into the lateral hypothalamic
nucleus on pancreatic secretion in conscious rats
A, microinjection of methscopolamine (MSCP) into the lateral hypothalamic nucleus (LH) resulted in a
significant decrease in unstimulated pancreatic secretion, indicating that basal cholinergic tone in the
hypothalamus regulates basal pancreatic secretion. B, time course of peptone-induced pancreatic secretion
in the presence and absence of MSCP. C, cumulative net increases in pancreatic protein output. MSCP
injection into the LH significantly reduced basal pancreatic protein secretion and peptone-stimulated
pancreatic protein secretion, suggesting that muscarinic cholinergic receptors in the hypothalamus are












Effects of microinjection of hemicholinium-3 into
the lateral cerebral ventricle on pancreatic secretion
A decrease in basal protein output from 308 ± 12 to
220 ± 7 mg h_1 (Fig. 4A) was observed 45 min after acute
injection of hemicholinium-3 (20 mg) into the lateral
cerebral ventricle of unanaesthetized rats. This treatment
also resulted in significant inhibition of luminally
stimulated pancreatic secretion (Fig. 4B). The respective
cumulative net increases in protein output were 70 ± 5
and 61 ± 3 mg (30 min)_1 in response to intraduodenal
peptone or hypertonic NaCl stimulation; reductions of
47 % and 51 % compared to controls (Fig. 4C).
Effects of microinjection of ACh into the LH, PVN,
dorsomedial hypothalamic nucleus (DMH), and
DMV on pancreatic secretion in conscious rats
Six rats were used for each nucleus injection study.
Microinjection of ACh at a dose of 5 or 50 pmol into the
DMH (n = 4) had no significant effect on pancreatic
secretion (Fig. 5F). Similarly, ACh injection outside the
DMH (perifornical nucleus and ventromedial hypothalamic
nucleus) (n = 2) had no effect on pancreatic secretion.
Microinjection of ACh at a dose of 5 pmol into the LH
(n = 5) (Fig. 5A) or PVN (n = 4) (Fig. 5B) induced an
increase in protein output from 318 ± 12 to 481 ± 10 and
475 ± 7 mg h_1, respectively. The increase was observed
after the 3-min injection and peaked within 15 min.
Microinjection of the M1 muscarinic receptor agonist
McN-A-343 (50 pmol) into the LH or PVN (Fig. 5C and
D) mimicked the stimulatory effects of ACh on pancreatic
secretion. Injection of ACh near, but outside the LH
(i.e. anterior hypothalamic area), or outside of the PVN
(i.e. reuniens nucleus or anterior hypothalamic area), did
not cause a significant increase in pancreatic secretion.
These observations indicate that stimulation of muscarinic
receptors in the hypothalamus evokes pancreatic protein
secretion. Microinjection sites in the hypothalamus are
shown in Fig. 6. Previous studies in which a similar
cannula injection technique was used showed that after
microinjection of [3H][3-methyl-His2]-TRH (50 nl) into
the preoptic nucleus more than 75 % of the radioactivity
was measured within a 600-mm diameter of the injection
site (Siren et al. 1991). Microinjection of ACh (5 or
50 pmol) into the DMV had no effect on pancreatic
secretion (n = 4) (Fig. 5E). In two rats, the injection sites
were found near the border of the hypoglossal nucleus. No
change in pancreatic secretion was observed.
Effects of selective lesion of cholinergic neurons in
the basal forebrain by 192 IgG-saporin
Immunohistochemistry confirmed that areas of the MS
(Fig. 7), LS, and NBM were nearly completely depleted of
ChAT-immunopositive neurons. No tissue necrosis or
nonspecific damage was observed. MS lesion and NBM
lesion had no effect on either basal pancreatic protein
secretion or pancreatic secretion stimulated by intra-
duodenal perfusion of peptone (Fig. 8A). In contrast, the
LS lesion resulted in a decrease in basal protein output
from 310 ± 7 to 212 ± 7 mg h_1 (Fig. 8A), and reduced the
cumulative net increases in protein output stimulated by
peptone from a control rate of 118 ± 6 mg (30 min)_1 to
80 ± 4 mg (30 min)_1, representing a 30 % inhibition
(Fig. 8B). These observations suggest that cholinergic
neurons in the LS are involved in modulating pancreatic
tone and protein secretion evoked by the vago-vagal reflex.
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Figure 4. Effects of microinjection of hemicholinium-3 into the lateral cerebral ventricle on
pancreatic secretion in conscious rats
Acute injection of hemicholinium-3 (HC-3, 20 mg) into the lateral cerebral ventricle of unanaesthetized rats
induced a decrease both in basal pancreatic secretion and in pancreatic secretion stimulated by
intraduodenal perfusion of peptone (A) and hypertonic saline (B). C, cumulative net increase in pancreatic
protein output in response to intraluminal peptone or hypertonic NaCl was significantly reduced after HC-3












Effects of PBN lesion on pancreatic protein secretion
in conscious rats
In five of nine rats, the neurotoxin ibotenic acid caused
well-placed, bilaterally symmetrical lesions of the LPBN.
Depictions of lesion damage in LPBN are shown in Fig. 9.
The locus and extent of the lesions were determined by the
loss of neurons and the presence of gliosis. The lesions
included the central, external, and to a lesser extent, the
dorsal and medial subnuclei of the LPBN (Fulwiler &
Saper, 1984). In two of the four remaining rats, the lesion
extended far enough ventrally to cause significant
unilateral damage to the MPBN. Of the remaining two
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Figure 5. Effects of microinjection of ACh and muscarinic M1 receptor agonist McN-A-343 into
the lateral hypothalamic nucleus, paraventricular nucleus, dorsomedial hypothalamic
nucleus, or dorsal motor nucleus of the vagus on pancreatic secretion in conscious rats
Microinjection of ACh (5 pmol) into the lateral hypothalamic nucleus (LH) (A) (n = 5) or the
paraventricular nucleus (PVN) (B) (n = 4) induced a marked increase in protein secretion. Similar results
were obtained after microinjection of McN-A-343 into the LH (C) or the PVN (D). In contrast,
microinjection of ACh at doses of 5 pmol or 50 pmol into the dorsal motor nucleus of the vagus (DMV) (E)
(n = 4) or the dorsomedial hypothalamic nucleus (DMH) (F) (n = 4) had no effect on pancreatic secretion.












rats, one had incomplete damage to the external lateral
subnucleus on both sides, and the other was in poor health.
Functional data from these four rats were excluded from
statistical analyses. In four of six MPBN-lesioned rats, the
ibotenic acid infusions produced well-placed lesions
located in the gustatory area of the PBN. In two rats,
damage to the gustatory area on both sides was
incomplete. Accordingly, data from these rats were
excluded from functional analyses. Neither MPBN nor
LPBN lesions significantly affected basal pancreatic
secretion in the conscious rat (Fig. 10A). MPBN lesion also
had no effect on pancreatic protein output stimulated by
duodenal perfusion of peptone. However, LPBN ibotenic
acid lesion caused a reduction in pancreatic protein
secretion stimulated by intraduodenal perfusion of
peptone (Fig. 10A). The cumulative net increase in protein
output was decreased from the control rate of
102 mg (30 min)_1 to 64 mg (30 min)_1 (Fig. 10B).
Effects of microinjection of glutamate into the LS
and LPBN on pancreatic vagal efferent nerve activity
and pancreatic protein secretion in anaesthetized
rats
We used glutamate as an agent for chemical stimulation.
This agent only activates the cell bodies without activating
the passing fibres. The vagal pancreatic efferent nerve
displayed low spontaneous activity. Microinjection of
saline had no effect on pancreatic nerve firings (Fig. 11A).
Microinjection of glutamate (30 nmol) into the LPBN
produced a marked increase in pancreatic nerve firings
(Fig. 11B) from a basal level of 0 ± 0.5 impulses (30 s)_1 to
14 ± 2 impulses (30 s)_1 in five rats tested. The response
reached a plateau 1 min after injection, and gradually
returned to baseline after 10 min. The distribution of
cannula placements in LPBN is shown in Fig 11E. Injection
into the LPBN was histologically confirmed in five of six
rats used in this study. LPBN injection sites were centred in
the central lateral and dorsal lateral portions of the LPBN
(Fulwiler & Saper, 1984). Injection reaching the ventral
lateral and external lateral portions were observed in some
rats; data from these rats were included in the analysis.
In one rat, the injection sites were located in the
mesencephalic nucleus and in the MBPN (Fig. 11E).
Glutamate injection had no effect on pancreatic nerve
firing in these rats.
In a separate study, injection into the LS was histologically
confirmed in all six rats. The LS injection sites were found
in both the rostral and caudal part of the lateral septal
nucleus. Microinjection of glutamate (30 nmol) into the
LS produced a mild increase in vagal pancreatic efferent
firings from a basal level of 0 ± 0.5 impulses (30 s)_1 to
4 ± 0.5 impulses (30 s)_1.
Given the fact that ACh did not act on DMV neurons to
stimulate pancreatic secretion, we tested the hypothesis
that ACh released from the LPBN activates neurons of the
hypothalamus, which in turn stimulates pancreatic
preganglionic motor neurons, and increases vagal efferent
activities. We showed that microinjection of 5 nmol
MSCP into the PVN significantly inhibited pancreatic
nerve firings evoked by LPBN injection of glutamate
(Fig. 11C). After pancreatic nerve recording studies, the
same anaesthetized rats were subjected to a pancreatic
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Figure 6. Location of microinjection sites of ACh in the
hypothalamus
Coronal sections adapted from the atlas of the rat brain by Paxinos
& Watson (1998) showing the ACh microinjection sites in the
hypothalamus. Numbers to the right of each section indicate the
distance from the bregma. Black circles, squares, and triangles
indicate the sites within the dorsomedial hypothalamic nucleus
(DMH), lateral hypothalamic nucleus (LH), and periventricular
hypothalamic nucleus (PVN), respectively. The grey symbols
indicate injection sites outside these target nuclei. AHP, anterior
hypothalamic area (posterior); VMH, ventromedial hypothalamic
nucleus; MPA, medial oreoptic area; DMH, dorsomedial
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Figure 7. Effect of 192 IgG-saporin on choline acetyltransferase-immunopositive neurons in
the medial septum
A, choline acetyltransferase (ChAT)-immunopositive neurons in a section of the medial septum (MS) from
sham-operated control rats. B, fewer ChAT-positive neurons are visible in a section of the MS region after
injection of 192 IgG-saporin. C and D, higher magnification of images depicted in A and B, respectively. Scale
bar B = 0.25 mm; D = 0.125 mm.
Figure 8. Effects of selective lesion of basal forebrain cholinergic neurons on pancreatic
secretion in conscious rats
The selective cholinergic toxin 192 IgG-saporin was used to lesion the neurons of the medial septum (MS),
the lateral septum (LS), and the nucleus basalis magnocellularis (NBM).  A, time course of peptone-induced
pancreatic secretion in control rats and in rats with lesions. MS or NBM lesions had no effect on basal
pancreatic output, nor did they affect pancreatic protein secretion stimulated by luminal perfusion of
peptone. In contrast, LS lesion resulted in a significant decrease in basal pancreatic output from 310 ± 7 to
212 ± 7 mg h_1, and a reduction in the cumulative net increase in protein output evoked by peptone from
118 ± 6 to 80 ± 4 mg (30 min)_1 (B), suggesting that cholinergic LS neurons play a role in regulating basal
and stimulated pancreatic secretion. Values are means ± S.E.M. for 4 rats in each group. * P < 0.05 compared












protein secretion study. Microinjection of glutamate into
the LPBN resulted in a correlated increase of pancreatic
protein output from a basal level of 123 ± 5 mg h_1 to
226 ± 11 mg h_1. PVN pretreatment with MSCP (5.0 nmol)
eliminated pancreatic protein secretion evoked by LPBN
injection of glutamate (Fig. 11D).
DISCUSSION
Exocrine pancreatic secretion is largely controlled by the
autonomic nervous system. We and other investigators
have clearly demonstrated that the vago-vagal reflex plays
a crucial role in the mediation of postprandial pancreatic
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Figure 9. Coronal sections through the dorsal pons
A, coronal section from a rat that received a PBS injection into the lateral parabrachial nucleus (LPBN).
B, coronal section after a well-placed injection of ibotenic acid into the LPBN. Scale bar = 0.8 mm. C and
D, higher magnification of images depicted in A and B, respectively. Sections were stained with cresyl violet.
MPBN, medial parabrachial nucleus; BC, brachium conjuctivum.
Figure 10. Effects of lateral or medial parabrachial nucleus lesions induced by ibotenic acid
on pancreatic secretion in conscious rats
A, time course of peptone-stimulated pancreatic secretion in control rats and in rats with lateral parabrachial
nucleus (LPBN) or medial PBN (MPBN) lesions. B, cumulative net increases in protein output stimulated by
peptone. Ibotenic acid treatment had no effect on basal pancreatic secretion. Lateral parabrachial nucleus
(LPBN) lesion significantly reduced pancreatic protein secretion in response to intraduodenal perfusion of
peptone, suggesting that LPBN neurons are involved in mediating pancreatic secretion evoked by the vago-
vagal reflex. Values are means ± S.E.M. for 4 rats with MPBN lesion and 5 rats with LPBN lesion. * P < 0.05
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Figure 11. Responses of the vagal pancreatic efferent nerve to microinjection of glutamate
into the lateral parabrachial nucleus, and the correlated pancreatic protein secretion in the
anaesthetized rat
Original action potentials are presented. A, vagal pancreatic efferent nerve displayed low spontaneous
activity. Microinjection of saline had no effect on pancreatic nerve firings. B, microinjection of glutamate
(30 nmol) into the lateral parabrachial nucleus (LPBN) produced a marked increase in pancreatic nerve
firings. The response reached a plateau 1 min after injection, and gradually returned to baseline after 10 min.
C, methscopolamine (MSCP, 5 nmol) injection into the periventricular hypothalamic nucleus (PVN)
abolished pancreatic nerve firings evoked by the LPBN injection of glutamate. D, glutamate microinjection
induced a correlated increase of pancreatic protein output in the anaesthetized rats. Pretreatment with
MSCP abolished pancreatic protein secretion evoked by LPBN injection of glutamate. Values are
means ± S.E.M. for 5 rats. * P < 0.05 compared with basal. E, coronal sections of the rat brain adapted from
the atlas of the rat brain by Paxinos & Watson (1998) showing the sites of glutamate microinjection in the
parabrachial nuclei. Black circles indicate injection sites within the LPBN; black squares indicate sites in the
medial parabrachial nucleus (MPBN) or the mesencephalic trigeminal tract (Me5). LPBC, lateral
parabrachial nucleus central; LPBD, lateral parabrachial nucleus central, dorsal; LPBE, lateral parabrachial
nucleus central, external; LPBI, lateral parabrachial nucleus, internal; 4V, 4th ventricle; MBP, medial












enzyme secretion. Previous studies in the rat have also
shown that CCK (Li & Owyang, 1993b, 1994; Li et al. 1997)
and luminal non-CCK-dependent factors (Li & Owyang,
1996a) such as osmolality, disaccharides, and mechanical
stimulation evoke pancreatic secretion via intestinal vagal
mucosal afferent fibres. We have demonstrated that 5-HT
released from intestinal enterochromaffin cells stimulates
both firing of vagal primary afferent neurons and
pancreatic secretion evoked by luminal non-CCK-
dependent factors (Li & Owyang, 1996a; Li et al. 2000; Zhu
et al. 2001). Although pancreatic secretion can be
mediated by vago-vagal reflexes located within the
brainstem, these reflexes may be modulated by input from
higher centres (Rogers et al. 1996). CNS control over the
cephalic phase of pancreatic secretion has been recognized
to be considerable since Pavlov’s time (Pavlov, 1910; Sarles
et al. 1968). Microinjection of thyrotropin-releasing
hormone or PP into the DMV has been shown to stimulate
or inhibit pancreatic secretion (Okumura et al. 1995a,b).
We have demonstrated that calcitonin gene-related
peptide and somatostatin inhibit pancreatic secretion at a
central vagal site (Li et al. 1998; Li & Owyang, 1993a). The
physiological importance of input from the forebrain on
postprandial pancreatic secretion, however, remains
largely unknown.
The hypothalamus plays a vital role in the processing and
integration of neurohumoral information arising from the
viscera. Gilsdorf et al. (1966) reported that electrical
stimulation of the ventromedial anterior hypothalamus of
conscious dogs induced an increase, whereas activation of
the posterior hypothalamus caused a decrease, in
pancreatic secretion. Mine et al. (1985) discovered that
electrolytic lesions of various nuclei in the amygdaloid
body in the rat affected pancreatic secretion in different
ways. To investigate the role of the forebrain in pancreatic
secretion, we conducted pancreatic secretion studies using
unanaesthetized chronic decerebrate rats that had
survived transection for an average of 14 days, a classical
method of removing forebrain influence. We showed that
chronic decerebrate rats are capable of retaining about
65 % of basal pancreatic protein output, and about 60 % of
pancreatic protein secretion stimulated by luminal
perfusion of peptone. These observations clearly indicate
that the caudal brainstem contains the neural network
sufficient to mediate the major part of basal pancreatic
tone and protein secretion stimulated by luminal agents.
However, the forebrain also plays an important role in
modulating the vago-vagal reflex in the brainstem.
Peripheral cholinergic blockade completely abolishes
pancreatic secretion evoked by CCK and non-CCK-
dependent luminal factors (Li & Owyang, 1993b, 1994,
1996a,b; Li et al. 1997, 2000). However, the site(s) of action
of peripherally administrated atropine is not clear.
Choline acetyltransferase immunoreactivity is abundant
in the nodose ganglia and the CNS; for example, in the
DMV, septal nuclei, PBN, bed nucleus, amygdala, and
hypothalamus (Quirion & Boksa, 1986; Portillo et al.
1996). Previous studies have shown that the central
cholinergic pathway contributes significantly to the
regulation of digestive functions including salivation
(Tomic-Beleslin & Beleslin, 1986), gastric secretion (Grill
& Norgren, 1978), gastric dysrhythmias (Hasler et al.
1995), emesis (Pedigo & Brizzee, 1985), and the
oesophagomotor response (Lu & Bieger, 1998). In the
current study, we showed that in conscious rats, I.C.V.
infusion of MSCP, a blood–brain barrier-impermeant
cholinergic muscarinic receptor antagonist significantly
decreased basal pancreatic protein output and reduced
pancreatic protein output stimulated by peptone and
NaCl, supporting the importance of the central
cholinergic pathway in the mediation of basal and
pancreatic secretion stimulated by luminal agents.
Surgical decerebration interrupts the entire descending
neural input to the brainstem. MSCP infused into the
lateral cerebral ventricle may flow into the third and fourth
ventricle and act on the vagal nuclei in the brainstem. In
this study, we demonstrated that MSCP microinjection
into the LH produced inhibitory effects similar to those
observed with surgical decerebration. Microinjection of
ACh into the LH or PVN stimulated pancreatic secretion.
However, injection of the same or higher doses of ACh into
the DMV did not affect pancreatic secretion. We have
shown that, in contrast to ACh, microinjection of
neuropeptide Y or substance P into the DMV markedly
increased pancreatic efferent nerve firings (Wu et al. 2002).
These observations suggest that the central cholinergic
pathway appears to function at the hypothalamus rather
than at medullary preganglionic motor neurons.
Viral retrograde transneuronal labelling has been used to
show that CNS cell groups project to the pancreatic
parasympathetic neurons (Loewy & Haxhiu, 1993).
Labelled neurons were evident in the PVN as well as in the
LH nucleus. The dorsal hypothalamic nuclei also
contained labelled neurons. A few labelled cells were found
in the peripheral DMH, but none in the ventromedial
hypothalamic nucleus. The DMH plays an important role
in the control of feeding, drinking, and body weight
(Bellinger & Bernardis, 2002). Our studies, however,
showed that microinjection of ACh into the DMH had no
significant effect on pancreatic protein output.
To investigate the role of endogenous ACh in the CNS on
basal and luminally stimulated pancreatic protein
secretion, the rats were pretreated with hemicholinium-3,
which selectively inhibits the high-affinity choline uptake
system and demonstrates specific binding to the
cholinergic regions of the rat brain (Rainbow et al. 1984),












apparently at presynaptic terminals that release ACh
(Quirion, 1985). The dose of hemicholinium-3 used in
this study caused maximum depletion of brain ACh in
spontaneous hypertensive rats (Brezenoff & Rusin, 1974;
Freeman et al. 1979). I.C.V. injection of hemicholinium-3
evoked a selective depressor response in unanaesthetized
spontaneous hypertensive rats, but not in normotensive
controls (Brezenoff & Caputi, 1980). In the present
study, we showed that 15 min after the injection of
hemicholinium-3 into the lateral cerebral ventricle, basal
pancreatic protein output was significantly decreased.
This treatment also produced partial inhibition of
pancreatic secretion stimulated by intraduodenal perfusion
of 5 % peptone and 600 mosmol l_1 NaCl. These
observations suggest that tonic cholinergic neuro-
transmission in the hypothalamus regulates basal
pancreatic tone and cholinergic mechanisms are involved
in modulating pancreatic secretion stimulated via the
vago-vagal reflex.
Autoradiographic studies have shown that dense areas of
muscarinic receptor binding sites occur throughout the
CNS, including the hypothalamus (Quirion & Boksa,
1986). The role of central muscarinic receptors in
pancreatic enzyme secretion has not been investigated.
The present study demonstrates that direct stimulation of
the hypothalamus by ACh causes an increase in pancreatic
secretion in conscious rats. Furthermore, microinjection
of the muscarinic M1 receptor specific agonist, McN-
A-343 (de Vries et al. 2001), produces a 40 % increase in
pancreatic secretion, suggesting that the M1 receptor in the
CNS is involved in the ACh-induced pancreatic secretion.
Efferent parasympathetic output originates from the DMV.
The hypothalamus has direct descending projections to
the dorsal vagal complex. Fluorescent tracer labelling
studies have shown that that hypothalamobular neurons
projecting to the DMV are most abundant in the ventral,
medial and lateral parts of the PVN (Portillo et al. 1996).
Electrophysiological studies have shown that the
hypothalamus plays an important role in the regulation of
the dorsal vagal complex. Stimulation of the LH excites
DMV neurons (Nishimura & Oomura, 1987) and
increases the activity of the axons in the hepatic branch of
the vagus (Yoshimatsu et al. 1988). Stimulation of the PVN
was shown to cause an increase in the spontaneous activity
of 59 % of PVN-sensitive DMV neurons and to cause a
decrease in the basal activity of 66 % of cells of the nucleus
of the solitary tract (Zhang et al. 1999). We recently
studied the DMV neural circuitry responsible for vagal
efferent signalling to the pancreas. We showed that
neuropeptide Y and substance P stimulated, while
somatostatin inhibited, pancreatic DMV preganglionic
neurons (Wu et al. 2001). Retrograde transneuronal viral
tracing studies provided strong anatomical evidence that
hypothalamic neurons project to the pancreas. After
injection of Bartha pseudorabies virus into the rat
pancreas, labelled transneuronal cell bodies were seen in
four hypothalamic nuclei: PVN, LH, and the dorsal and
dorsomedial hypothalamic nuclei (Jansen et al. 1997).
PVN labelling was restricted to the parvicellular subnuclei.
Within the LH area, infected neurons were found in the
perifornical area and in the caudal area at the level of
the subthalamic nuclei. These anatomical observations
support our current findings, and suggest that under
physiological conditions, the hypothalamic cholinergic
system may tonically stimulate preganglionic DMV
neurons projecting to the pancreas.
Cholinergic cell bodies are distributed throughout the
brain, and cholinergic axons innervate most regions of the
CNS. There are two major sources of cholinergic neurons
in the basal forebrain, the septal nuclei and the nucleus
basalis of Meynert (Butcher & Woolf, 1984; Kimura et al.
1984), which project to the cortex, hippocampus,
amygdala, thalamus and brainstem (Butcher & Woolf,
1984).
The LS is a large cell mass located in the rostrodorsal septal
region. Study of the connections of the rat lateral septal
complex has demonstrated that this nucleus receives
major descending input from the hippocampal formation,
which converges with ascending input from many parts of
the hypothalamus and brainstem. LS projections are
known to innervate the hypothalamus (Risold & Swanson,
1997). Electrophysiological recordings have shown that LS
stimulation evokes an increase in the excitability of rat
hypothalamic neurons (Blume et al. 1982; Kendrick,
1983). Ablation of the lateral septum with ibotenate
decreased choline acetyltransferase concentrations in the
PVN, suggesting that cholinergic innervation of these
areas is septal in origin (Oorjitham et al. 1989). The NBM,
which is analogous to the nucleus basalis of Meynert in
humans, is another source of cholinergic neurons in the rat
basal forebrain. Many cholinergic neurons in the basal
forebrain express high levels of the low-affinity p75 NGFr
(Gage et al. 1989). When 192 IgG, the monoclonal
antibody to p75 NGFr, is coupled to the ribosomal-
inactivating protein saporin, it selectively destroys
neurons bearing NGFr in in vivo rats (Book et al. 1992;
Wiley, 1992). It has been reported that a septal injection of
this immunotoxin selectively destroys cholinergic cells but
spares NGFr-negative noncholinergic neurons within the
basal forebrain (Wenk et al. 1994; Lee et al. 1994). In the
current study, we performed a series of experiments to
identify the sites of cholinergic neurons that are responsible
for the modulation of basal and stimulated pancreatic
secretion. We showed that MS or NBM cholinergic
neuronal lesions had no effect on either basal pancreatic
protein secretion or pancreatic protein secretion
stimulated by intraduodenal perfusion of peptone. In
contrast, lesion of the LS resulted in a decrease of basal












protein output, and a 30 % reduction of the cumulative net
increase in protein output stimulated by peptone.
There is another conspicuous zone of cholinergic
neurons in the lateral tegmental area of the rostral
rhombencephalon (Butcher & Woolf, 1984; Kimura et al.
1984; Rye et al. 1987), including the pedunculopontine
(e.g. parabrachial nucleus) and laterodorsal tegmental
nuclei. The PBN sends direct input to the hypothalamic
nuclei, including the LH and PVN (Saper & Loewy, 1980;
Fulwiler & Saper, 1984). This anatomical evidence raises
the possibility that the pontine nuclei may be involved in
the activation of the LH and PVN via cholinergic
pathways. Further, it is possible that afferent inputs from
the gastrointestinal tract reach the LPBN. (Herbert et al.
1990). In situ hybridization autoradiography has shown
that 45 min after intragastric HCl challenge, many
neurons in the NTS, LPBN, and hypothalamic PVN
express c-fos mRNA (Michl et al. 2001). Immuno-
histochemical studies have shown that intestinal perfusion
of dietary glucose induces c-fos expression in the NTS,
area postrema, and LPBN (Wang et al. 1999). More
recently, neurophysiological recording studies have
suggested that oral and gastrointestinal sensory signals
converge to activate the neurons in the LPBN (Karimnamazi
et al. 2002). In the present study, we showed that neither
MPBN lesion nor LPBN lesion had a significant effect on
basal pancreatic secretion in the conscious rat. Further,
MPBN lesion did not affect pancreatic protein output
stimulated by duodenal perfusion of peptone. LPBN
ibotenic acid lesion, in contrast, inhibited peptone-
induced pancreatic protein by 40 %. Electrophysiological
studies showed that microinjection of glutamate into the
LS and the LPBN stimulated vagal pancreatic efferent
nerve firing, and these responses were blocked by
microinjection of a cholinergic antagonist into the PVN.
Considered together, these observations suggest that
cholinergic neurons in the LS are responsible for
maintaining pancreatic tone. These neurons also are
involved in modulating stimulated pancreatic secretion.
LPBN cholinergic input to the hypothalamus plays a major
role in the modulation of vagal pancreatic efferent nerve
activity and pancreatic protein secretion stimulated by the
vago-vagal reflex.
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